Literature DB >> 32235144

Multimodal Analgesic Regimen for Spine Surgery: A Randomized Placebo-controlled Trial.

Kamal Maheshwari1, Rafi Avitsian, Daniel I Sessler, Natalya Makarova, Marianne Tanios, Syed Raza, David Traul, Shobana Rajan, Mariel Manlapaz, Sandra Machado, Ajit Krishnaney, Andre Machado, Richard Rosenquist, Andrea Kurz.   

Abstract

BACKGROUND: Various multimodal analgesic approaches have been proposed for spine surgery. The authors evaluated the effect of using a combination of four nonopioid analgesics versus placebo on Quality of Recovery, postoperative opioid consumption, and pain scores.
METHODS: Adults having multilevel spine surgery who were at high risk for postoperative pain were double-blind randomized to placebos or the combination of single preoperative oral doses of acetaminophen 1,000 mg and gabapentin 600 mg, an infusion of ketamine 5 µg/kg/min throughout surgery, and an infusion of lidocaine 1.5 mg/kg/h intraoperatively and during the initial hour of recovery. Postoperative analgesia included acetaminophen, gabapentin, and opioids. The primary outcome was the Quality of Recovery 15-questionnaire (0 to 150 points, with 15% considered to be a clinically important difference) assessed on the third postoperative day. Secondary outcomes were opioid use in morphine equivalents (with 20% considered to be a clinically important change) and verbal-response pain scores (0 to 10, with a 1-point change considered important) over the initial postoperative 48 h.
RESULTS: The trial was stopped early for futility per a priori guidelines. The average duration ± SD of surgery was 5.4 ± 2.1 h. The mean ± SD Quality of Recovery score was 109 ± 25 in the pathway patients (n = 150) versus 109 ± 23 in the placebo group (n = 149); estimated difference in means was 0 (95% CI, -6 to 6, P = 0.920). Pain management within the initial 48 postoperative hours was not superior in analgesic pathway group: 48-h opioid consumption median (Q1, Q3) was 72 (48, 113) mg in the analgesic pathway group and 75 (50, 152) mg in the placebo group, with the difference in medians being -9 (97.5% CI, -23 to 5, P = 0.175) mg. Mean 48-h pain scores were 4.8 ± 1.8 in the analgesic pathway group versus 5.2 ± 1.9 in the placebo group, with the difference in means being -0.4 (97.5% CI; -0.8, 0.1, P = 0.094).
CONCLUSIONS: An analgesic pathway based on preoperative acetaminophen and gabapentin, combined with intraoperative infusions of lidocaine and ketamine, did not improve recovery in patients who had multilevel spine surgery.

Entities:  

Year:  2020        PMID: 32235144     DOI: 10.1097/ALN.0000000000003143

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  12 in total

1.  Evaluation of the Effect of Continuous Infusion of Dexmedetomidine or a Subanesthetic Dose Ketamine on Transcranial Electrical Motor Evoked Potentials in Adult Patients Undergoing Elective Spine Surgery under Total Intravenous Anesthesia: A Randomized Controlled Exploratory Study.

Authors:  Roshan Andleeb; Sanjay Agrawal; Priyanka Gupta
Journal:  Asian Spine J       Date:  2021-08-20

2.  Opioid-free Anesthesia: Time to Regain Our Balance.

Authors:  Evan D Kharasch; J David Clark
Journal:  Anesthesiology       Date:  2021-04-01       Impact factor: 7.892

3.  Low Incidence of Opioid-Induced Respiratory Depression Observed with Oliceridine Regardless of Age or Body Mass Index: Exploratory Analysis from a Phase 3 Open-Label Trial in Postsurgical Pain.

Authors:  Marek Brzezinski; Gregory B Hammer; Keith A Candiotti; Sergio D Bergese; Peter H Pan; Michael H Bourne; Cathy Michalsky; Linda Wase; Mark A Demitrack; Ashraf S Habib
Journal:  Pain Ther       Date:  2021-01-21

4.  Opioid-free anesthesia for patients with joint hypermobility syndrome undergoing craneo-cervical fixation: a case-series study focused on anti-hyperalgesic approach.

Authors:  Carlos Ramírez-Paesano; Albert Juanola Galceran; Claudia Rodiera Clarens; Vicenҫ Gilete García; Bartolomé Oliver Abadal; Verónica Vilchez Cobo; Bibiana Ros Nebot; Sara Julián González; Lucía Cao López; Jesús Santaliestra Fierro; Josep Rodiera Olivé
Journal:  Orphanet J Rare Dis       Date:  2021-04-13       Impact factor: 4.123

Review 5.  Perioperative Low-Dose Ketamine for Postoperative Pain Management in Spine Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Lijin Zhou; Honghao Yang; Yong Hai; Yunzhong Cheng
Journal:  Pain Res Manag       Date:  2022-03-31       Impact factor: 3.037

6.  The duration of chronic low back pain is associated with acute postoperative pain intensity in lumbar fusion surgery: a prospective observational study.

Authors:  Mei-Ping Qian; Mei-Rong Dong; Juan Li; Fang Kang
Journal:  BMC Anesthesiol       Date:  2022-04-29       Impact factor: 2.376

Review 7.  Management of Postoperative Pain in Patients Following Spine Surgery: A Narrative Review.

Authors:  Nitin K Prabhakar; Andrea L Chadwick; Chinwe Nwaneshiudu; Anuj Aggarwal; Vafi Salmasi; Theresa R Lii; Jennifer M Hah
Journal:  Int J Gen Med       Date:  2022-05-02

8.  Pathway for enhanced recovery after spinal surgery-a systematic review of evidence for use of individual components.

Authors:  Ana Licina; Andrew Silvers; Harry Laughlin; Jeremy Russell; Crispin Wan
Journal:  BMC Anesthesiol       Date:  2021-03-10       Impact factor: 2.217

9.  Increasing the use of multimodal analgesia during adult surgery in a tertiary academic anaesthesia department.

Authors:  Andrea V Olmos; Sasha Steen; Christy K Boscardin; Joyce M Chang; Genevieve Manahan; Anthony R Little; Man-Cheung Lee; Linda L Liu
Journal:  BMJ Open Qual       Date:  2021-07

10.  Oliceridine Exhibits Improved Tolerability Compared to Morphine at Equianalgesic Conditions: Exploratory Analysis from Two Phase 3 Randomized Placebo and Active Controlled Trials.

Authors:  Gregory B Hammer; Ashish K Khanna; Cathy Michalsky; Linda Wase; Mark A Demitrack; Roderick Little; Michael J Fossler; Sabry Ayad
Journal:  Pain Ther       Date:  2021-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.